TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07507838: Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules in Chinese Healthy Participants

Sponsor: Vigonvita Life Sciences · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 24 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$4,131,408

Rescue Site Savings

+$2,731,696

Unlock Full NCT07507838 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07507838 Rescue Dossier →